Press release
-
Press Release
VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
First Reporting Quarter as Valion Bio Marked by Continued Advancement of the Entolimod Platform, Broader Government Engagement, and Continued Integration…
Read More » -
Press Release
Vuzix Reports First Quarter 2026 Results
ROCHESTER, N.Y., May 14, 2026 /PRNewswire/ — Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of AI-powered…
Read More » -
Press Release
Pixelworks Reports First Quarter 2026 Financial Results
PORTLAND, Ore., May 14, 2026 /PRNewswire/ — Pixelworks, Inc. (NASDAQ: PXLW) (“Pixelworks” or the “Company”), a provider of innovative cinematic…
Read More » -
Press Release
Research Solutions Reports Third Quarter Fiscal Year 2026 Results
Reports 8.5% Increase in ARR to $22.1 Million, Net Income of $860,000 and 14% Year-over-Year Growth in Adjusted EBITDA HENDERSON,…
Read More » -
Press Release
Fermi Board Amends Bylaws to Protect Interests of Shareholders
DALLAS, May 14, 2026 /PRNewswire/ — Fermi Inc. (NASDAQ: FRMI) (LSE: FRMI), operating as Fermi America™ (“Fermi” or the “Company”), today announced…
Read More » -
Press Release
MetaVia Reports First Quarter 2026 Financial Results and Provides Corporate Update
48 mg Phase 1 Data Demonstrated Potential Best-in-Class Profile for DA-1726 with 9.1% Weight Loss, Improved Glucose Control and Direct…
Read More » -
Press Release
Inhibrx Reports First Quarter 2026 Financial Results
SAN DIEGO, May 14, 2026 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”) today reported financial results…
Read More » -
Press Release
Co-Diagnostics Reports First Quarter 2026 Financial Results
Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion Executing Clinical Strategy with Upper Respiratory Submission Preparation and TB…
Read More »
